Victoza Injection (Liraglutide)


SKU: N/A Category:



Victoza. Indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with a body mass index (BMI) of ≥30 (obesity) or adults with a BMI of ≥27 (overweight) who have at least 1 weight-related condition (eg, hypertension, type 2 diabetes, dyslipidemia). buy online victoza

Initiate at 0.6 mg SC qDay for 1 week; increase by 0.6 mg/day in weekly intervals until a dose of 3 mg/day is achieved

If patients do not tolerate an increased dose during dose escalation, consider delaying dose escalation for ~1 additional week

Discontinue if a patient cannot tolerate the 3 mg dose, as efficacy has not been established at lower doses (eg, 0.6, 1.2, 1.8, 2.4 mg)

Dosage Modifications (Victoza)

Renal impairment

Mild-to-severe, including patients with end-stage renal disease (ESRD): Limited experience
There have been postmarketing reports of acute renal failure and worsening of chronic renal failure with liraglutide, which may sometimes require hemodialysis; use with caution in these patients
Hepatic impairment
Mild-to-severe: Use caution; limited experience

Dosage Modifications (Victoza): buy online victoza

Renal impairment

Mild-to-severe: No dosage adjustment necessary
Patients with ESRD: Limited experience; there have been postmarketing reports of acute renal failure and worsening of chronic renal failure, which may sometimes require hemodialysis; use caution in patients who experience dehydration
Hepatic impairment
Mild-to-severe: Limited experience; no dosage adjustment necessary
Dosing Considerations
Saxenda slows gastric emptying; has not been studied in patients with pre-existing gastroparesis

Limitations of use for Victoza: buy online victoza

Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis (not effective for these conditions)
Has not been studied in combination with prandial insulin
Limitations of use for Saxenda
Not indicated for the treatment of type 2 diabetes mellitus
Saxenda and Victoza both contain liraglutide, and therefore should not be used together or in combination with any other GLP-1 receptor agonist
Not studied in patients taking insulin; do not use with insulin
Safety and effectiveness in combination with other products intended for weight loss, including prescription drugs, OTCs, and herbal products, have not been established

Additional information


1 pen injector 0,6mg/0,1ml (18mg/3ml), 12 pen injector 0,6mg/0,1ml (18mg/3ml), 3 pen injector 0,6mg/0,1ml (18mg/3ml), 6 pen injector 0,6mg/0,1ml (18mg/3ml)


There are no reviews yet.

Be the first to review “Victoza Injection (Liraglutide)”

Your email address will not be published. Required fields are marked *